biomaterial-based cancer/melanoma vaccines, implantable (Novartis)
N/A
Report date: 2025/02/01 20:00:06
Base Information
Drug Namebiomaterial-based cancer/melanoma vaccines, implantable (Novartis)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWyss Institute for Biologically Inspired Engineering
China Registration ClassN/A
Develop Information
Active CompaniesNovartis Ag
Inactive CompaniesWyss Institute for Biologically Inspired Engineering
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A